Author Correction: A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention (Scientific Reports, (2023), 13, 1, (2502), 10.1038/s41598-023-29006-z)

Ahram Han, Taeseung Lee, Joongyub Lee, Suk‑Won Song, Sang‑Su Lee, In Mok Jung, Jin Mo Kang, Jun Gyo Gwon, Woo‑Sung Yun, Yong‑Pil Cho, Hyunmin Ko, Yang‑Jin Park, Seung‑Kee Min

Research output: Contribution to journalComment/debate

Abstract

The original version of this Article contained an error in Affiliation 6, which was incorrectly given as ‘Division of Vascular and Endovascular Surgery, Department of Surgery, Yangsan Hospital, Pusan National University, Yangsan, South Korea’. The correct affiliation is listed below. Division of Vascular and Endovascular Surgery, Department of Surgery, School of Medicine, Pusan National University, Pusan National University Yangsan Hospital, Yangsan, South Korea. The original Article has been corrected.

Original languageEnglish
Article number18234
JournalScientific Reports
Volume14
Issue number1
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'Author Correction: A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention (Scientific Reports, (2023), 13, 1, (2502), 10.1038/s41598-023-29006-z)'. Together they form a unique fingerprint.

Cite this